Genprex Restates 2018 Equity Incentive Plan, Effective April 15
The biotech company amended and restated its stock-award plan to reflect regulatory changes and prior reverse stock splits.
By the FiledFeed automated desk
This summary was generated by AI from the company's SEC filing and may contain errors — always verify against the primary source on SEC.gov.
The short version
Genprex, Inc. amended and restated its 2018 Equity Incentive Plan effective April 15, 2026, according to an 8-K filing on June 18, 2026. The restatement reflects adjustments for the company's one-for-40 reverse stock split on February 2, 2024, and one-for-50 reverse stock split on October 21, 2025, and incorporates regulatory updates. The plan requires stockholder approval within 12 months of the restatement date.
Filing impact
Filing sentiment
Genprex, Inc. (GNPX) filed an 8-K on June 18, 2026, reporting that it has amended and restated its 2018 Equity Incentive Plan, effective April 15, 2026.
The restatement updates the plan to reflect changes in the company's share structure resulting from two reverse stock splits: a one-for-40 split on February 2, 2024, and a one-for-50 split on October 21, 2025. All share numbers and related data in the plan have been adjusted accordingly.
The updated plan sets limits on awards granted to outside directors at $1,000,000 per fiscal year, or $2,000,000 in connection with an initial service as an outside director. It also includes clawback provisions (the ability to reclaim awarded compensation) to comply with stock exchange listing rules and federal law.
The plan includes detailed terms governing stock options, restricted stock, and performance-based awards, as well as rules for what happens to awards in the event of a change of control (such as a merger or acquisition). It also specifies how awards are treated if a participant's employment terminates, and defines fair market value and performance metrics that may be used in setting award targets.
According to the filing, Genprex must obtain stockholder approval of the restated plan within 12 months of the April 15, 2026 restatement date.
Key facts
- Genprex, Inc. (ticker: GNPX) amended and restated its 2018 Equity Incentive Plan effective April 15, 2026
- Company implemented one-for-40 reverse stock split on February 2, 2024, and one-for-50 reverse stock split on October 21, 2025
- Plan restatement adjusts all share numbers and related data to reflect the reverse splits
- Outside director award limit: $1,000,000 per fiscal year, or $2,000,000 for initial service
- Plan includes clawback provisions per stock exchange listing rules and the Dodd-Frank Act
- Stockholder approval required within 12 months of the restatement date (by April 15, 2027)
- 8-K filing date: June 18, 2026
Why it matters
Genprex's restatement of its equity incentive plan is a routine administrative update prompted by the company's reverse stock splits, which are often used by struggling companies to maintain compliance with stock exchange minimum price rules. The restatement ensures that all equity awards granted to employees and directors reflect the adjusted share count and complies with current securities laws and exchange listing standards. Stockholder approval within 12 months is a procedural requirement that confirms the board's authority to use the plan going forward.
Frequently asked
- Why did Genprex restate its equity incentive plan?
- The restatement reflects adjustments for the company's one-for-40 reverse stock split on February 2, 2024, and one-for-50 reverse stock split on October 21, 2025. All share numbers and related data in the plan were adjusted to account for these splits.
- What is the limit on awards to outside directors?
- Outside directors can receive awards with a grant date fair value of up to $1,000,000 per fiscal year, or $2,000,000 in connection with their initial service as a director.
- When must stockholders approve the restated plan?
- Stockholders must approve the restated plan within 12 months of the April 15, 2026 restatement date, which means by April 15, 2027.
- What are clawback provisions in the plan?
- Clawback provisions allow the company to reclaim or recover compensation awards under certain circumstances, such as a violation of company policy or required by stock exchange rules and federal law.
What the filing reported
- 5.02 Departure/Election of Directors or Officers
- 5.07 Other reported item
- 9.01 Financial Statements & Exhibits
Source
Based on Genprex, Inc.'s 8-K filed with the SEC on Jun 18, 2026. Read the original filing on SEC.gov ↗